CUX1 mediates tumour cell survival: implications for future therapies?
Malek
Nisar P
NP
Department of Gastroenterology, Hepatology and Endocrinology and Institute for Molecular Biology, Hannover Medical School, 130625 Hannover, Germany. malek.nisar@mh-hannover.de
D002470:Cell Survival / Q000502:physiology; D019008:Drug Resistance, Neoplasm; D018398:Homeodomain Proteins / Q000502:physiology*; D006801:Humans; D009363:Neoplasm Proteins / Q000502:physiology*; D009687:Nuclear Proteins / Q000502:physiology*; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology*; D012097:Repressor Proteins / Q000502:physiology*; D014157:Transcription Factors
C080632:CUX1 protein, human; D018398:Homeodomain Proteins; D009363:Neoplasm Proteins; D009687:Nuclear Proteins; D012097:Repressor Proteins; D014157:Transcription Factors